The future of the global pharmaceutical quality control market looks promising with opportunities in the vaccine, plasma product and drug markets. The global pharmaceutical quality control market is expected to reach an estimated $3.8 billion by 2030 with a CAGR of 13.2% from 2024 to 2030. The major drivers for this market are rising expenses associated with pharmaceutical manufacturing, growing focus on patient's safety, and increasing market for generic drug.
Some of the Key Questions answered in this exclusive report are:
Q.1. What are some of the most promising, high-growth opportunities for the pharmaceutical quality control market by product (consumables, instruments, and services), analysis type (sterility testing, bioburden testing, endotoxin testing, stability testing, extractable & leachable testing, raw material testing, and others), products tested (vaccines, plasma product, and drugs), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Market Segmentation:
In this market, consumable, instrument, and service are the major segments of pharmaceutical quality control market by product.
Lucintel forecasts that consumables will remain the largest segment over the forecast period.
Within this market, vaccine will remain the largest segment due to growing requirement of critical solutions for quality assurance.
North America will remain the largest region over the forecast period due to advanced healthcare systems and growing cases of chronic diseases in the region.
Biomerieux, Charles River Laboratories International, WiXi Apptec, Merck, and Thermo Fisher Scientific are the major suppliers in the pharmaceutical quality control market.